Cargando…
Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans
Rabies kills many people throughout the developing world every year. The murine monoclonal antibody (mAb) 62-71-3 was recently identified for its potential application in rabies postexposure prophylaxis (PEP). The purpose here was to establish a plant-based production system for a chimeric mouse-hum...
Autores principales: | Both, Leonard, van Dolleweerd, Craig, Wright, Edward, Banyard, Ashley C., Bulmer-Thomas, Bianca, Selden, David, Altmann, Friedrich, Fooks, Anthony R., Ma, Julian K.-C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Federation of American Societies for Experimental Biology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633812/ https://www.ncbi.nlm.nih.gov/pubmed/23371065 http://dx.doi.org/10.1096/fj.12-219964 |
Ejemplares similares
-
Monoclonal antibodies for prophylactic and therapeutic use against viral infections
por: Both, Leonard, et al.
Publicado: (2013) -
Monoclonal antibodies for prophylactic and therapeutic use against viral infections()
por: Both, Leonard, et al.
Publicado: (2013) -
Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
por: van Dolleweerd, Craig J., et al.
Publicado: (2014) -
Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2022) -
Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2021)